Search papers, labs, and topics across Lattice.
1
0
0
40
Next-generation CD40L and CD40 antagonists offer a potentially safer and more effective approach to managing B cell-driven autoimmune diseases by overcoming the safety concerns associated with first-generation anti-CD40L antibodies.
